Optical coherence tomography skin screening system from MedLumics debuts

Optical coherence tomography (OCT) imaging device specialist MedLumics introduced its NITID skin imaging system at the 23rd Annual European Academy of Dermatology and Venereology Congress (EADV).

Oct 27th, 2014

Optical coherence tomography (OCT) imaging device specialist MedLumics (Madrid, Spain) introduced its NITID skin imaging system at the 23rd Annual European Academy of Dermatology and Venereology Congress (EADV; Amsterdam, The Netherlands) held October 8-12, 2014. The minimally invasive NITID handheld diagnostic device helps dermatologists to quickly diagnose skin cancer. Once approved by regulatory bodies, it will be the first point-of-care OCT imaging device that can produce dynamic, real-time, high-resolution diagnostic images with tissue penetration capability of up to 2 mm.

Related: OCT developments address skin cancer diagnosis

The NITID device combines epiluminescence microscopy and OCT imaging in a patent-protected, built-in display that integrates seamlessly with current patient-centered workflows. By means of infrared (IR) light, this diagnostic image modality is able to obtain sectional images with micrometric resolution from the inside of biological tissues noninvasively.

More in Bioimaging